ainewsblitz.com

Breaking

GSK Expands AI Drug-Discovery Alliance With Relation Therapeutics in Deal Worth Up to $110 Million

GSK Expands AI Drug-Discovery Alliance With Relation Therapeutics in Deal Worth Up to $110 Million
  • Healthcare
  • Foundation Models
  • Funding & M&A

GSK Plc has broadened its artificial-intelligence partnership with UK biotech Relation Therapeutics Ltd., agreeing to a collaboration that could pay the startup as much as $110 million in upfront and success-based milestone payments as the pharmaceutical giant seeks to accelerate early-stage drug discovery.

Continue reading

The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.

$20
Read this article
$29/month
Unlimited — all 27,934 articles, the full archive, and comprehension quizzes
Save 72%
$98/year
≈ $8.17/month
Unlimited, billed once a year